Stem Cell Factor (SCF) is a putative biomarker of antidepressant response

Francesco Benedetti, Sara Poletti, Thomas A. Hoogenboezem, Clara Locatelli, Oliver Ambrée, Harm de Wit, Annemarie J M Wijkhuijs, Elena Mazza, Chiara Bulgarelli, Benedetta Vai, Cristina Colombo, Enrico Smeraldi, Volker Arolt, Hemmo A. Drexhage

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Growth factors involved in neurogenesis and neuroplasticity could play a role in biological processes that drive depression recovery. Combined total sleep deprivation and morning light therapy (TSD + LT) can acutely reverse depressive symptoms, thus allowing to investigate the neurobiological correlates of antidepressant response. We tested if changes on plasma levels of Brain Derived Neurotrophic Factor (BDNF), S100 calcium binding protein B (S100-B), Stem Cell Factor (SCF), Insulin-like Growth Factor-Binding Protein 2 (IGFBP-2), Epidermal Growth Factor (EGF), Platelet-Derived Growth Factor-BB (PDGF-BB), and Vascular Endothelial Growth Factor (VEGF) are associated with response to TSD + LT in 26 inpatients affected by a major depressive episode in the course of bipolar disorder. Regional grey matter (GM) volumes were assessed at baseline, and BOLD fMRI neural responses to a moral valence decision task were recorded before and after treatment. 61.5 % of patients responded to treatment. SCF plasma levels increased significantly more in responders, and correlated with GM volumes in frontal and parietal cortical areas. The pattern of change of SCF also associated with both GM volumes and changes of BOLD fMRI neural responses in the anterior cingulate and medial prefrontal cortex. SCF is both a hematopoietic growth factor and a neurotrophic factor, involved in neuron-neuron and neuron-(micro) glia interactions, fostering neuronal growth and an anti-inflammatory milieu. We correlated SCF levels with antidepressant response and with functional and structural MRI measures in cortical areas that are involved in the cognitive generation and control of affect. SCF may be a candidate growth factor that contributes to neurotrophic and immune effects that are involved in the process of remission/recovery from depression.

Original languageEnglish
Pages (from-to)248-258
Number of pages11
JournalJournal of NeuroImmune Pharmacology
Volume11
Issue number2
DOIs
Publication statusPublished - Jun 1 2016

Fingerprint

Stem Cell Factor
Antidepressive Agents
Biomarkers
Intercellular Signaling Peptides and Proteins
Magnetic Resonance Imaging
Depression
Neurons
Insulin-Like Growth Factor Binding Protein 2
Biological Phenomena
Neuronal Plasticity
Calcium-Binding Proteins
Sleep Deprivation
Phototherapy
Foster Home Care
Gyrus Cinguli
Brain-Derived Neurotrophic Factor
Neurogenesis
Nerve Growth Factors
Prefrontal Cortex
Bipolar Disorder

Keywords

  • Antidepressant
  • Biomarker
  • Bipolar Disorder
  • Neuroinflammation
  • Neurotrophins
  • Stem cell factor

ASJC Scopus subject areas

  • Pharmacology
  • Immunology and Allergy
  • Immunology
  • Neuroscience (miscellaneous)

Cite this

Benedetti, F., Poletti, S., Hoogenboezem, T. A., Locatelli, C., Ambrée, O., de Wit, H., ... Drexhage, H. A. (2016). Stem Cell Factor (SCF) is a putative biomarker of antidepressant response. Journal of NeuroImmune Pharmacology, 11(2), 248-258. https://doi.org/10.1007/s11481-016-9672-y

Stem Cell Factor (SCF) is a putative biomarker of antidepressant response. / Benedetti, Francesco; Poletti, Sara; Hoogenboezem, Thomas A.; Locatelli, Clara; Ambrée, Oliver; de Wit, Harm; Wijkhuijs, Annemarie J M; Mazza, Elena; Bulgarelli, Chiara; Vai, Benedetta; Colombo, Cristina; Smeraldi, Enrico; Arolt, Volker; Drexhage, Hemmo A.

In: Journal of NeuroImmune Pharmacology, Vol. 11, No. 2, 01.06.2016, p. 248-258.

Research output: Contribution to journalArticle

Benedetti, F, Poletti, S, Hoogenboezem, TA, Locatelli, C, Ambrée, O, de Wit, H, Wijkhuijs, AJM, Mazza, E, Bulgarelli, C, Vai, B, Colombo, C, Smeraldi, E, Arolt, V & Drexhage, HA 2016, 'Stem Cell Factor (SCF) is a putative biomarker of antidepressant response', Journal of NeuroImmune Pharmacology, vol. 11, no. 2, pp. 248-258. https://doi.org/10.1007/s11481-016-9672-y
Benedetti, Francesco ; Poletti, Sara ; Hoogenboezem, Thomas A. ; Locatelli, Clara ; Ambrée, Oliver ; de Wit, Harm ; Wijkhuijs, Annemarie J M ; Mazza, Elena ; Bulgarelli, Chiara ; Vai, Benedetta ; Colombo, Cristina ; Smeraldi, Enrico ; Arolt, Volker ; Drexhage, Hemmo A. / Stem Cell Factor (SCF) is a putative biomarker of antidepressant response. In: Journal of NeuroImmune Pharmacology. 2016 ; Vol. 11, No. 2. pp. 248-258.
@article{68fcd4b8a51243058ffa2220c5278902,
title = "Stem Cell Factor (SCF) is a putative biomarker of antidepressant response",
abstract = "Growth factors involved in neurogenesis and neuroplasticity could play a role in biological processes that drive depression recovery. Combined total sleep deprivation and morning light therapy (TSD + LT) can acutely reverse depressive symptoms, thus allowing to investigate the neurobiological correlates of antidepressant response. We tested if changes on plasma levels of Brain Derived Neurotrophic Factor (BDNF), S100 calcium binding protein B (S100-B), Stem Cell Factor (SCF), Insulin-like Growth Factor-Binding Protein 2 (IGFBP-2), Epidermal Growth Factor (EGF), Platelet-Derived Growth Factor-BB (PDGF-BB), and Vascular Endothelial Growth Factor (VEGF) are associated with response to TSD + LT in 26 inpatients affected by a major depressive episode in the course of bipolar disorder. Regional grey matter (GM) volumes were assessed at baseline, and BOLD fMRI neural responses to a moral valence decision task were recorded before and after treatment. 61.5 {\%} of patients responded to treatment. SCF plasma levels increased significantly more in responders, and correlated with GM volumes in frontal and parietal cortical areas. The pattern of change of SCF also associated with both GM volumes and changes of BOLD fMRI neural responses in the anterior cingulate and medial prefrontal cortex. SCF is both a hematopoietic growth factor and a neurotrophic factor, involved in neuron-neuron and neuron-(micro) glia interactions, fostering neuronal growth and an anti-inflammatory milieu. We correlated SCF levels with antidepressant response and with functional and structural MRI measures in cortical areas that are involved in the cognitive generation and control of affect. SCF may be a candidate growth factor that contributes to neurotrophic and immune effects that are involved in the process of remission/recovery from depression.",
keywords = "Antidepressant, Biomarker, Bipolar Disorder, Neuroinflammation, Neurotrophins, Stem cell factor",
author = "Francesco Benedetti and Sara Poletti and Hoogenboezem, {Thomas A.} and Clara Locatelli and Oliver Ambr{\'e}e and {de Wit}, Harm and Wijkhuijs, {Annemarie J M} and Elena Mazza and Chiara Bulgarelli and Benedetta Vai and Cristina Colombo and Enrico Smeraldi and Volker Arolt and Drexhage, {Hemmo A.}",
year = "2016",
month = "6",
day = "1",
doi = "10.1007/s11481-016-9672-y",
language = "English",
volume = "11",
pages = "248--258",
journal = "Journal of NeuroImmune Pharmacology",
issn = "1557-1890",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - Stem Cell Factor (SCF) is a putative biomarker of antidepressant response

AU - Benedetti, Francesco

AU - Poletti, Sara

AU - Hoogenboezem, Thomas A.

AU - Locatelli, Clara

AU - Ambrée, Oliver

AU - de Wit, Harm

AU - Wijkhuijs, Annemarie J M

AU - Mazza, Elena

AU - Bulgarelli, Chiara

AU - Vai, Benedetta

AU - Colombo, Cristina

AU - Smeraldi, Enrico

AU - Arolt, Volker

AU - Drexhage, Hemmo A.

PY - 2016/6/1

Y1 - 2016/6/1

N2 - Growth factors involved in neurogenesis and neuroplasticity could play a role in biological processes that drive depression recovery. Combined total sleep deprivation and morning light therapy (TSD + LT) can acutely reverse depressive symptoms, thus allowing to investigate the neurobiological correlates of antidepressant response. We tested if changes on plasma levels of Brain Derived Neurotrophic Factor (BDNF), S100 calcium binding protein B (S100-B), Stem Cell Factor (SCF), Insulin-like Growth Factor-Binding Protein 2 (IGFBP-2), Epidermal Growth Factor (EGF), Platelet-Derived Growth Factor-BB (PDGF-BB), and Vascular Endothelial Growth Factor (VEGF) are associated with response to TSD + LT in 26 inpatients affected by a major depressive episode in the course of bipolar disorder. Regional grey matter (GM) volumes were assessed at baseline, and BOLD fMRI neural responses to a moral valence decision task were recorded before and after treatment. 61.5 % of patients responded to treatment. SCF plasma levels increased significantly more in responders, and correlated with GM volumes in frontal and parietal cortical areas. The pattern of change of SCF also associated with both GM volumes and changes of BOLD fMRI neural responses in the anterior cingulate and medial prefrontal cortex. SCF is both a hematopoietic growth factor and a neurotrophic factor, involved in neuron-neuron and neuron-(micro) glia interactions, fostering neuronal growth and an anti-inflammatory milieu. We correlated SCF levels with antidepressant response and with functional and structural MRI measures in cortical areas that are involved in the cognitive generation and control of affect. SCF may be a candidate growth factor that contributes to neurotrophic and immune effects that are involved in the process of remission/recovery from depression.

AB - Growth factors involved in neurogenesis and neuroplasticity could play a role in biological processes that drive depression recovery. Combined total sleep deprivation and morning light therapy (TSD + LT) can acutely reverse depressive symptoms, thus allowing to investigate the neurobiological correlates of antidepressant response. We tested if changes on plasma levels of Brain Derived Neurotrophic Factor (BDNF), S100 calcium binding protein B (S100-B), Stem Cell Factor (SCF), Insulin-like Growth Factor-Binding Protein 2 (IGFBP-2), Epidermal Growth Factor (EGF), Platelet-Derived Growth Factor-BB (PDGF-BB), and Vascular Endothelial Growth Factor (VEGF) are associated with response to TSD + LT in 26 inpatients affected by a major depressive episode in the course of bipolar disorder. Regional grey matter (GM) volumes were assessed at baseline, and BOLD fMRI neural responses to a moral valence decision task were recorded before and after treatment. 61.5 % of patients responded to treatment. SCF plasma levels increased significantly more in responders, and correlated with GM volumes in frontal and parietal cortical areas. The pattern of change of SCF also associated with both GM volumes and changes of BOLD fMRI neural responses in the anterior cingulate and medial prefrontal cortex. SCF is both a hematopoietic growth factor and a neurotrophic factor, involved in neuron-neuron and neuron-(micro) glia interactions, fostering neuronal growth and an anti-inflammatory milieu. We correlated SCF levels with antidepressant response and with functional and structural MRI measures in cortical areas that are involved in the cognitive generation and control of affect. SCF may be a candidate growth factor that contributes to neurotrophic and immune effects that are involved in the process of remission/recovery from depression.

KW - Antidepressant

KW - Biomarker

KW - Bipolar Disorder

KW - Neuroinflammation

KW - Neurotrophins

KW - Stem cell factor

UR - http://www.scopus.com/inward/record.url?scp=84964285633&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964285633&partnerID=8YFLogxK

U2 - 10.1007/s11481-016-9672-y

DO - 10.1007/s11481-016-9672-y

M3 - Article

VL - 11

SP - 248

EP - 258

JO - Journal of NeuroImmune Pharmacology

JF - Journal of NeuroImmune Pharmacology

SN - 1557-1890

IS - 2

ER -